E2 of hepatitis C virus inhibits apoptosis

Song Hee Lee, Yoon Ki Kim, Chon Saeng Kim, Su Kyoung Seol, Joonhyun Kim, Sungchan Cho, Young Lan Song, Ralf Bartenschlager, Sung Key Jang

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Hepatitis C virus (HCV) is the major causative agent of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma, and can be involved in very long chronic infections up to 30 years or more. Therefore, it has been speculated that HCV possesses mechanisms capable of modulating host defense systems such as innate and adaptive immunity. To investigate this virus-host interaction, we generated HCV replicons containing various HCV structural proteins and then analyzed the sensitivity of replicon-containing cells to the apoptosis-inducing agent, TRAIL. TRAIL-induced apoptosis was monitored by cleavage of procaspase-3 and procaspase-9 as well as that of their substrate poly(ADP-ribose) polymerase. TRAIL-induced apoptosis was inhibited in cells expressing HCV E2. Moreover, expression of HCV E2 enhanced the colony forming efficiency of replicon-containing cells by 25-fold. Blockage of apoptosis by E2 seems to be related to inhibition of TRAIL-induced cytochrome c release from the mitochondria. Based on these results, we propose that E2 augments persistent HCV infection by blocking host-induced apoptosis of infected cells.

Original languageEnglish
Pages (from-to)8226-8235
Number of pages10
JournalJournal of Immunology
Volume175
Issue number12
Publication statusPublished - 2005 Dec 15
Externally publishedYes

Fingerprint

Hepacivirus
Apoptosis
Replicon
Viral Structural Proteins
Poly(ADP-ribose) Polymerases
Caspase 9
Adaptive Immunity
Virus Diseases
Chronic Hepatitis
Cytochromes c
Innate Immunity
Caspase 3
Liver Cirrhosis
Hepatocellular Carcinoma
Mitochondria
Viruses
Infection

ASJC Scopus subject areas

  • Immunology

Cite this

Lee, S. H., Kim, Y. K., Kim, C. S., Seol, S. K., Kim, J., Cho, S., ... Jang, S. K. (2005). E2 of hepatitis C virus inhibits apoptosis. Journal of Immunology, 175(12), 8226-8235.

E2 of hepatitis C virus inhibits apoptosis. / Lee, Song Hee; Kim, Yoon Ki; Kim, Chon Saeng; Seol, Su Kyoung; Kim, Joonhyun; Cho, Sungchan; Song, Young Lan; Bartenschlager, Ralf; Jang, Sung Key.

In: Journal of Immunology, Vol. 175, No. 12, 15.12.2005, p. 8226-8235.

Research output: Contribution to journalArticle

Lee, SH, Kim, YK, Kim, CS, Seol, SK, Kim, J, Cho, S, Song, YL, Bartenschlager, R & Jang, SK 2005, 'E2 of hepatitis C virus inhibits apoptosis', Journal of Immunology, vol. 175, no. 12, pp. 8226-8235.
Lee SH, Kim YK, Kim CS, Seol SK, Kim J, Cho S et al. E2 of hepatitis C virus inhibits apoptosis. Journal of Immunology. 2005 Dec 15;175(12):8226-8235.
Lee, Song Hee ; Kim, Yoon Ki ; Kim, Chon Saeng ; Seol, Su Kyoung ; Kim, Joonhyun ; Cho, Sungchan ; Song, Young Lan ; Bartenschlager, Ralf ; Jang, Sung Key. / E2 of hepatitis C virus inhibits apoptosis. In: Journal of Immunology. 2005 ; Vol. 175, No. 12. pp. 8226-8235.
@article{3237a7f55c1445bc9bb8490e8e7e2d12,
title = "E2 of hepatitis C virus inhibits apoptosis",
abstract = "Hepatitis C virus (HCV) is the major causative agent of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma, and can be involved in very long chronic infections up to 30 years or more. Therefore, it has been speculated that HCV possesses mechanisms capable of modulating host defense systems such as innate and adaptive immunity. To investigate this virus-host interaction, we generated HCV replicons containing various HCV structural proteins and then analyzed the sensitivity of replicon-containing cells to the apoptosis-inducing agent, TRAIL. TRAIL-induced apoptosis was monitored by cleavage of procaspase-3 and procaspase-9 as well as that of their substrate poly(ADP-ribose) polymerase. TRAIL-induced apoptosis was inhibited in cells expressing HCV E2. Moreover, expression of HCV E2 enhanced the colony forming efficiency of replicon-containing cells by 25-fold. Blockage of apoptosis by E2 seems to be related to inhibition of TRAIL-induced cytochrome c release from the mitochondria. Based on these results, we propose that E2 augments persistent HCV infection by blocking host-induced apoptosis of infected cells.",
author = "Lee, {Song Hee} and Kim, {Yoon Ki} and Kim, {Chon Saeng} and Seol, {Su Kyoung} and Joonhyun Kim and Sungchan Cho and Song, {Young Lan} and Ralf Bartenschlager and Jang, {Sung Key}",
year = "2005",
month = "12",
day = "15",
language = "English",
volume = "175",
pages = "8226--8235",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "12",

}

TY - JOUR

T1 - E2 of hepatitis C virus inhibits apoptosis

AU - Lee, Song Hee

AU - Kim, Yoon Ki

AU - Kim, Chon Saeng

AU - Seol, Su Kyoung

AU - Kim, Joonhyun

AU - Cho, Sungchan

AU - Song, Young Lan

AU - Bartenschlager, Ralf

AU - Jang, Sung Key

PY - 2005/12/15

Y1 - 2005/12/15

N2 - Hepatitis C virus (HCV) is the major causative agent of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma, and can be involved in very long chronic infections up to 30 years or more. Therefore, it has been speculated that HCV possesses mechanisms capable of modulating host defense systems such as innate and adaptive immunity. To investigate this virus-host interaction, we generated HCV replicons containing various HCV structural proteins and then analyzed the sensitivity of replicon-containing cells to the apoptosis-inducing agent, TRAIL. TRAIL-induced apoptosis was monitored by cleavage of procaspase-3 and procaspase-9 as well as that of their substrate poly(ADP-ribose) polymerase. TRAIL-induced apoptosis was inhibited in cells expressing HCV E2. Moreover, expression of HCV E2 enhanced the colony forming efficiency of replicon-containing cells by 25-fold. Blockage of apoptosis by E2 seems to be related to inhibition of TRAIL-induced cytochrome c release from the mitochondria. Based on these results, we propose that E2 augments persistent HCV infection by blocking host-induced apoptosis of infected cells.

AB - Hepatitis C virus (HCV) is the major causative agent of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma, and can be involved in very long chronic infections up to 30 years or more. Therefore, it has been speculated that HCV possesses mechanisms capable of modulating host defense systems such as innate and adaptive immunity. To investigate this virus-host interaction, we generated HCV replicons containing various HCV structural proteins and then analyzed the sensitivity of replicon-containing cells to the apoptosis-inducing agent, TRAIL. TRAIL-induced apoptosis was monitored by cleavage of procaspase-3 and procaspase-9 as well as that of their substrate poly(ADP-ribose) polymerase. TRAIL-induced apoptosis was inhibited in cells expressing HCV E2. Moreover, expression of HCV E2 enhanced the colony forming efficiency of replicon-containing cells by 25-fold. Blockage of apoptosis by E2 seems to be related to inhibition of TRAIL-induced cytochrome c release from the mitochondria. Based on these results, we propose that E2 augments persistent HCV infection by blocking host-induced apoptosis of infected cells.

UR - http://www.scopus.com/inward/record.url?scp=29144519760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29144519760&partnerID=8YFLogxK

M3 - Article

C2 - 16339562

AN - SCOPUS:29144519760

VL - 175

SP - 8226

EP - 8235

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 12

ER -